Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122525) titled 'Precise Quantification of LA-NSCLC Heterogeneity and Prediction of Treatment Response and Prognosis Based on 18F-FDG PET/CT Metabolic Habitat Imaging' on April 14.
Study Type: Observational study
Study Design:
Case study
Primary Sponsor: the Second Qilu Hospital of Shandong University
Condition:
Lung cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-15
Target Sample Size: Case series:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=315395
Disclaimer: Curated by HT Syndication....